Start Date
June 30, 2012
Primary Completion Date
December 31, 2013
Curosurf®
Initial dose is 2.5ml/kg (200 mg/kg phospholipid) administered via endotracheal tube. Subsequent doses if needed are 1.25 mL/kg (100 mg/kg phospholipids).
Survanta®
Initial dose is 4 mL/kg (100 mg/kg phospholipids) administered via endotracheal tube. Subsequent doses if needed are 4 mL/kg (100 mg/kg phospholipids).
University of Michigan C & W Mott Children's Hospital, Ann Arbor
Collaborators (1)
Cornerstone Pharmaceuticals
INDUSTRY
University of Michigan
OTHER